Moca Network, supported by Animoca Brands, signed a Memorandum of Understanding with Inveo Kripto and Ichain to develop regulated Web3 infrastructure in Türkiye, a leading country in crypto adoption. The partnership will integrate Moca's AIR Kit for reusable KYC, stablecoin transactions, and digital identity interoperability into Turkish platforms, aiming to simplify crypto service access. They will also explore real-world asset tokenization and compliant digital banking, leveraging Inveo Kripto's regulatory license. This move aligns with Moca Network’s broader plan to launch Moca Chain, an identity-focused blockchain, with key milestones expected by the end of 2025. Investors should watch for AIR Kit deployment and Moca Chain’s testnet and mainnet launches to gauge success.
The global reactive hot melt adhesives market is projected to grow from $2.02 billion in 2025 to $4.29 billion by 2035, at a CAGR of 7.72%. Growth is driven by regulations limiting solvent-based adhesives, increased use of polyurethane adhesives in a...
The global automotive microcontrollers market is projected to grow from USD 15.49 billion in 2025 to USD 34.31 billion by 2035, at a CAGR of 8.28%. Growth is fueled by increasing adoption of advanced driver-assistance systems (ADAS), vehicle electrif...
CHARBONE Corporation has increased its helium delivery fleet from one to five units to meet rising demand caused by global helium supply disruptions, notably from Qatar. This expansion supports North American customers in sectors like semiconductors ...
Citi has started coverage of Hikma Pharmaceuticals with a 'buy' rating and a £17 price target, highlighting the company's strategic shift towards differentiated products and US manufacturing investments. The broker sees a 14% potential share price re...
Xenon Pharmaceuticals is evolving into a late-stage, cash-rich neuroscience company with a validated Kv7 potassium channel platform. Its lead drug candidate, azetukalner, has shown strong effectiveness in treating refractory focal onset seizures and ...
